On October 29, 2026, EDGE MEDICAL-B repurchased 85,500 H shares on the SEHK open market at an average of HKD 31.3779 per share, involving about HKD 2.68 million; this was an on-exchange active trade matched on the SEHK open market (a direct secondary-market dealing), and because Jianchen Wang is deemed to be interested in the company’s treasury shares under the SFO due to his control of one-third or more of the voting power, his long position increased.
Prior to the acquisition, Jianchen Wang’s long position in EDGE MEDICAL-B was 124.31 million shares, representing 37.93%; following the acquisition, the holding changed to 124.39 million shares, with the long position ratio rising to 37.95%.
Comments